Loading…
Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations
Identifying potential factors correlated with the sustained presence of antibodies in plasma may facilitate improved retrospective diagnoses and aid in the appraisal of pertinent vaccination strategies for various demographic groups. The main objective was to describe the persistence of anti-spike I...
Saved in:
Published in: | Pathogens (Basel) 2024-07, Vol.13 (8), p.622 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c376t-3c1df29233492a1026c7cd8e59edf8bfafb74870f970bf451fe4d2e45a24932f3 |
container_end_page | |
container_issue | 8 |
container_start_page | 622 |
container_title | Pathogens (Basel) |
container_volume | 13 |
creator | Pons-Tomàs, Gemma Pino, Rosa Soler-García, Aleix Launes, Cristian Martínez-de-Albeniz, Irene Ríos-Barnés, María Melé-Casas, Maria Hernández-García, María Monsonís, Manuel Gené, Amadeu de-Sevilla, Mariona-F García-García, Juan-José Fortuny, Claudia Fumadó, Victoria |
description | Identifying potential factors correlated with the sustained presence of antibodies in plasma may facilitate improved retrospective diagnoses and aid in the appraisal of pertinent vaccination strategies for various demographic groups. The main objective was to describe the persistence of anti-spike IgG one year after diagnosis in children and analyse its levels in relation to epidemiological and clinical variables.
A prospective, longitudinal, observational study was conducted in a university reference hospital in the Metropolitan Region of Barcelona (Spain) (March 2020-May 2021). This study included patients under 18 years of age with SARS-CoV-2 infection (positive PCR or antigen tests for SARS-CoV-2). Clinical and serological follow-up one year after infection was performed.
We included 102 patients with a median age of 8.8 years. Anti-spike IgG was positive in 98/102 (96%) 12 months after the infection. There were higher anti-spike IgG levels were noted in patients younger than 2 years (
= 0.034) and those with pneumonia (
< 0.001). A positive and significant correlation was observed between C-reactive protein at diagnosis and anti-spike IgG titre one-year after diagnosis (
= 0.027).
Anti-SARS-CoV-2 IgG antibodies were detected in almost all paediatric patients one year after infection. We also observed a positive correlation between virus-specific IgG antibody titres with SARS-CoV-2 clinical phenotype (pneumonia) and age (under 2 years old). |
doi_str_mv | 10.3390/pathogens13080622 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3f47ce0abc554ccda1a82332b8586596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3f47ce0abc554ccda1a82332b8586596</doaj_id><sourcerecordid>3097997862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-3c1df29233492a1026c7cd8e59edf8bfafb74870f970bf451fe4d2e45a24932f3</originalsourceid><addsrcrecordid>eNplkltrFDEYhgdRbKn9Ad5IwBtvRnOYQ-KNLOuhhQWlqwWvhkzyZSZLNtkm2cL-E3-uM24trQZCTu_7fEl4i-IlwW8ZE_jdTuYxDOATYZjjhtInxSnFbVNiTtqnD-YnxXlKGzw1juf18-KECYorStlp8esjKLsbIVo_oDwCWgU_wK3NByS9Riu4BZdQMGi9uFqXy3BdUrTw2fZBW0jIerQcrdMR_Hu0QD9BxnImoHXe6wO6sMPopp5n-tJZb5V06NsIPuTDbvLPNRYDlFfgZAaNrmW0Mtvg04vimZEuwfndeFb8-Pzp-_KiXH39crlcrErF2iaXTBFtqKCMVYJKgmmjWqU51AK04b2Rpm8r3mIjWtybqiYGKk2hqiWtBKOGnRWXR64OctPtot3KeOiCtN2fjRCHTsZslYOOmapVgGWv6rpSSksi-VSY9rzmTS2aifXhyNrt-y1oBT5H6R5BH594O3ZDuO0IYXVLqpnw5o4Qw80eUu62NilwTnoI-9QxLEQrasJn6et_pJuwj376q1nVTjre0ElFjioVQ0oRzP1tCO7mHHX_5WjyvHr4jHvH39Sw3yYpxpY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097997862</pqid></control><display><type>article</type><title>Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Pons-Tomàs, Gemma ; Pino, Rosa ; Soler-García, Aleix ; Launes, Cristian ; Martínez-de-Albeniz, Irene ; Ríos-Barnés, María ; Melé-Casas, Maria ; Hernández-García, María ; Monsonís, Manuel ; Gené, Amadeu ; de-Sevilla, Mariona-F ; García-García, Juan-José ; Fortuny, Claudia ; Fumadó, Victoria</creator><creatorcontrib>Pons-Tomàs, Gemma ; Pino, Rosa ; Soler-García, Aleix ; Launes, Cristian ; Martínez-de-Albeniz, Irene ; Ríos-Barnés, María ; Melé-Casas, Maria ; Hernández-García, María ; Monsonís, Manuel ; Gené, Amadeu ; de-Sevilla, Mariona-F ; García-García, Juan-José ; Fortuny, Claudia ; Fumadó, Victoria</creatorcontrib><description>Identifying potential factors correlated with the sustained presence of antibodies in plasma may facilitate improved retrospective diagnoses and aid in the appraisal of pertinent vaccination strategies for various demographic groups. The main objective was to describe the persistence of anti-spike IgG one year after diagnosis in children and analyse its levels in relation to epidemiological and clinical variables.
A prospective, longitudinal, observational study was conducted in a university reference hospital in the Metropolitan Region of Barcelona (Spain) (March 2020-May 2021). This study included patients under 18 years of age with SARS-CoV-2 infection (positive PCR or antigen tests for SARS-CoV-2). Clinical and serological follow-up one year after infection was performed.
We included 102 patients with a median age of 8.8 years. Anti-spike IgG was positive in 98/102 (96%) 12 months after the infection. There were higher anti-spike IgG levels were noted in patients younger than 2 years (
= 0.034) and those with pneumonia (
< 0.001). A positive and significant correlation was observed between C-reactive protein at diagnosis and anti-spike IgG titre one-year after diagnosis (
= 0.027).
Anti-SARS-CoV-2 IgG antibodies were detected in almost all paediatric patients one year after infection. We also observed a positive correlation between virus-specific IgG antibody titres with SARS-CoV-2 clinical phenotype (pneumonia) and age (under 2 years old).</description><identifier>ISSN: 2076-0817</identifier><identifier>EISSN: 2076-0817</identifier><identifier>DOI: 10.3390/pathogens13080622</identifier><identifier>PMID: 39204223</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Antibodies ; Asymptomatic ; C-reactive protein ; Correlation ; COVID-19 ; COVID-19 vaccines ; Demographic variables ; Diagnosis ; Epidemiology ; Families & family life ; Fever ; Glycoproteins ; hospitalisation ; IgG antibody ; Immunity (Disease) ; Immunoassay ; Immunoglobulin G ; Infections ; Metropolitan areas ; Observational studies ; paediatrics ; Pandemics ; Patients ; Pediatrics ; Phenotypes ; Phenotypic variations ; Pneumonia ; Population ; Proteins ; SARS-CoV-2 ; Serology ; Severe acute respiratory syndrome coronavirus 2 ; Vaccination ; Variables ; Viral diseases</subject><ispartof>Pathogens (Basel), 2024-07, Vol.13 (8), p.622</ispartof><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c376t-3c1df29233492a1026c7cd8e59edf8bfafb74870f970bf451fe4d2e45a24932f3</cites><orcidid>0000-0003-0059-8607 ; 0000-0002-0913-9303 ; 0000-0002-3483-528X ; 0000-0001-6035-7106</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3097997862/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3097997862?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39204223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pons-Tomàs, Gemma</creatorcontrib><creatorcontrib>Pino, Rosa</creatorcontrib><creatorcontrib>Soler-García, Aleix</creatorcontrib><creatorcontrib>Launes, Cristian</creatorcontrib><creatorcontrib>Martínez-de-Albeniz, Irene</creatorcontrib><creatorcontrib>Ríos-Barnés, María</creatorcontrib><creatorcontrib>Melé-Casas, Maria</creatorcontrib><creatorcontrib>Hernández-García, María</creatorcontrib><creatorcontrib>Monsonís, Manuel</creatorcontrib><creatorcontrib>Gené, Amadeu</creatorcontrib><creatorcontrib>de-Sevilla, Mariona-F</creatorcontrib><creatorcontrib>García-García, Juan-José</creatorcontrib><creatorcontrib>Fortuny, Claudia</creatorcontrib><creatorcontrib>Fumadó, Victoria</creatorcontrib><title>Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations</title><title>Pathogens (Basel)</title><addtitle>Pathogens</addtitle><description>Identifying potential factors correlated with the sustained presence of antibodies in plasma may facilitate improved retrospective diagnoses and aid in the appraisal of pertinent vaccination strategies for various demographic groups. The main objective was to describe the persistence of anti-spike IgG one year after diagnosis in children and analyse its levels in relation to epidemiological and clinical variables.
A prospective, longitudinal, observational study was conducted in a university reference hospital in the Metropolitan Region of Barcelona (Spain) (March 2020-May 2021). This study included patients under 18 years of age with SARS-CoV-2 infection (positive PCR or antigen tests for SARS-CoV-2). Clinical and serological follow-up one year after infection was performed.
We included 102 patients with a median age of 8.8 years. Anti-spike IgG was positive in 98/102 (96%) 12 months after the infection. There were higher anti-spike IgG levels were noted in patients younger than 2 years (
= 0.034) and those with pneumonia (
< 0.001). A positive and significant correlation was observed between C-reactive protein at diagnosis and anti-spike IgG titre one-year after diagnosis (
= 0.027).
Anti-SARS-CoV-2 IgG antibodies were detected in almost all paediatric patients one year after infection. We also observed a positive correlation between virus-specific IgG antibody titres with SARS-CoV-2 clinical phenotype (pneumonia) and age (under 2 years old).</description><subject>Age</subject><subject>Antibodies</subject><subject>Asymptomatic</subject><subject>C-reactive protein</subject><subject>Correlation</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Demographic variables</subject><subject>Diagnosis</subject><subject>Epidemiology</subject><subject>Families & family life</subject><subject>Fever</subject><subject>Glycoproteins</subject><subject>hospitalisation</subject><subject>IgG antibody</subject><subject>Immunity (Disease)</subject><subject>Immunoassay</subject><subject>Immunoglobulin G</subject><subject>Infections</subject><subject>Metropolitan areas</subject><subject>Observational studies</subject><subject>paediatrics</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Phenotypes</subject><subject>Phenotypic variations</subject><subject>Pneumonia</subject><subject>Population</subject><subject>Proteins</subject><subject>SARS-CoV-2</subject><subject>Serology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Vaccination</subject><subject>Variables</subject><subject>Viral diseases</subject><issn>2076-0817</issn><issn>2076-0817</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNplkltrFDEYhgdRbKn9Ad5IwBtvRnOYQ-KNLOuhhQWlqwWvhkzyZSZLNtkm2cL-E3-uM24trQZCTu_7fEl4i-IlwW8ZE_jdTuYxDOATYZjjhtInxSnFbVNiTtqnD-YnxXlKGzw1juf18-KECYorStlp8esjKLsbIVo_oDwCWgU_wK3NByS9Riu4BZdQMGi9uFqXy3BdUrTw2fZBW0jIerQcrdMR_Hu0QD9BxnImoHXe6wO6sMPopp5n-tJZb5V06NsIPuTDbvLPNRYDlFfgZAaNrmW0Mtvg04vimZEuwfndeFb8-Pzp-_KiXH39crlcrErF2iaXTBFtqKCMVYJKgmmjWqU51AK04b2Rpm8r3mIjWtybqiYGKk2hqiWtBKOGnRWXR64OctPtot3KeOiCtN2fjRCHTsZslYOOmapVgGWv6rpSSksi-VSY9rzmTS2aifXhyNrt-y1oBT5H6R5BH594O3ZDuO0IYXVLqpnw5o4Qw80eUu62NilwTnoI-9QxLEQrasJn6et_pJuwj376q1nVTjre0ElFjioVQ0oRzP1tCO7mHHX_5WjyvHr4jHvH39Sw3yYpxpY</recordid><startdate>20240726</startdate><enddate>20240726</enddate><creator>Pons-Tomàs, Gemma</creator><creator>Pino, Rosa</creator><creator>Soler-García, Aleix</creator><creator>Launes, Cristian</creator><creator>Martínez-de-Albeniz, Irene</creator><creator>Ríos-Barnés, María</creator><creator>Melé-Casas, Maria</creator><creator>Hernández-García, María</creator><creator>Monsonís, Manuel</creator><creator>Gené, Amadeu</creator><creator>de-Sevilla, Mariona-F</creator><creator>García-García, Juan-José</creator><creator>Fortuny, Claudia</creator><creator>Fumadó, Victoria</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0059-8607</orcidid><orcidid>https://orcid.org/0000-0002-0913-9303</orcidid><orcidid>https://orcid.org/0000-0002-3483-528X</orcidid><orcidid>https://orcid.org/0000-0001-6035-7106</orcidid></search><sort><creationdate>20240726</creationdate><title>Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations</title><author>Pons-Tomàs, Gemma ; Pino, Rosa ; Soler-García, Aleix ; Launes, Cristian ; Martínez-de-Albeniz, Irene ; Ríos-Barnés, María ; Melé-Casas, Maria ; Hernández-García, María ; Monsonís, Manuel ; Gené, Amadeu ; de-Sevilla, Mariona-F ; García-García, Juan-José ; Fortuny, Claudia ; Fumadó, Victoria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-3c1df29233492a1026c7cd8e59edf8bfafb74870f970bf451fe4d2e45a24932f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Antibodies</topic><topic>Asymptomatic</topic><topic>C-reactive protein</topic><topic>Correlation</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Demographic variables</topic><topic>Diagnosis</topic><topic>Epidemiology</topic><topic>Families & family life</topic><topic>Fever</topic><topic>Glycoproteins</topic><topic>hospitalisation</topic><topic>IgG antibody</topic><topic>Immunity (Disease)</topic><topic>Immunoassay</topic><topic>Immunoglobulin G</topic><topic>Infections</topic><topic>Metropolitan areas</topic><topic>Observational studies</topic><topic>paediatrics</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Phenotypes</topic><topic>Phenotypic variations</topic><topic>Pneumonia</topic><topic>Population</topic><topic>Proteins</topic><topic>SARS-CoV-2</topic><topic>Serology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Vaccination</topic><topic>Variables</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pons-Tomàs, Gemma</creatorcontrib><creatorcontrib>Pino, Rosa</creatorcontrib><creatorcontrib>Soler-García, Aleix</creatorcontrib><creatorcontrib>Launes, Cristian</creatorcontrib><creatorcontrib>Martínez-de-Albeniz, Irene</creatorcontrib><creatorcontrib>Ríos-Barnés, María</creatorcontrib><creatorcontrib>Melé-Casas, Maria</creatorcontrib><creatorcontrib>Hernández-García, María</creatorcontrib><creatorcontrib>Monsonís, Manuel</creatorcontrib><creatorcontrib>Gené, Amadeu</creatorcontrib><creatorcontrib>de-Sevilla, Mariona-F</creatorcontrib><creatorcontrib>García-García, Juan-José</creatorcontrib><creatorcontrib>Fortuny, Claudia</creatorcontrib><creatorcontrib>Fumadó, Victoria</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Pathogens (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pons-Tomàs, Gemma</au><au>Pino, Rosa</au><au>Soler-García, Aleix</au><au>Launes, Cristian</au><au>Martínez-de-Albeniz, Irene</au><au>Ríos-Barnés, María</au><au>Melé-Casas, Maria</au><au>Hernández-García, María</au><au>Monsonís, Manuel</au><au>Gené, Amadeu</au><au>de-Sevilla, Mariona-F</au><au>García-García, Juan-José</au><au>Fortuny, Claudia</au><au>Fumadó, Victoria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations</atitle><jtitle>Pathogens (Basel)</jtitle><addtitle>Pathogens</addtitle><date>2024-07-26</date><risdate>2024</risdate><volume>13</volume><issue>8</issue><spage>622</spage><pages>622-</pages><issn>2076-0817</issn><eissn>2076-0817</eissn><abstract>Identifying potential factors correlated with the sustained presence of antibodies in plasma may facilitate improved retrospective diagnoses and aid in the appraisal of pertinent vaccination strategies for various demographic groups. The main objective was to describe the persistence of anti-spike IgG one year after diagnosis in children and analyse its levels in relation to epidemiological and clinical variables.
A prospective, longitudinal, observational study was conducted in a university reference hospital in the Metropolitan Region of Barcelona (Spain) (March 2020-May 2021). This study included patients under 18 years of age with SARS-CoV-2 infection (positive PCR or antigen tests for SARS-CoV-2). Clinical and serological follow-up one year after infection was performed.
We included 102 patients with a median age of 8.8 years. Anti-spike IgG was positive in 98/102 (96%) 12 months after the infection. There were higher anti-spike IgG levels were noted in patients younger than 2 years (
= 0.034) and those with pneumonia (
< 0.001). A positive and significant correlation was observed between C-reactive protein at diagnosis and anti-spike IgG titre one-year after diagnosis (
= 0.027).
Anti-SARS-CoV-2 IgG antibodies were detected in almost all paediatric patients one year after infection. We also observed a positive correlation between virus-specific IgG antibody titres with SARS-CoV-2 clinical phenotype (pneumonia) and age (under 2 years old).</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39204223</pmid><doi>10.3390/pathogens13080622</doi><orcidid>https://orcid.org/0000-0003-0059-8607</orcidid><orcidid>https://orcid.org/0000-0002-0913-9303</orcidid><orcidid>https://orcid.org/0000-0002-3483-528X</orcidid><orcidid>https://orcid.org/0000-0001-6035-7106</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2076-0817 |
ispartof | Pathogens (Basel), 2024-07, Vol.13 (8), p.622 |
issn | 2076-0817 2076-0817 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_3f47ce0abc554ccda1a82332b8586596 |
source | Open Access: PubMed Central; Publicly Available Content Database |
subjects | Age Antibodies Asymptomatic C-reactive protein Correlation COVID-19 COVID-19 vaccines Demographic variables Diagnosis Epidemiology Families & family life Fever Glycoproteins hospitalisation IgG antibody Immunity (Disease) Immunoassay Immunoglobulin G Infections Metropolitan areas Observational studies paediatrics Pandemics Patients Pediatrics Phenotypes Phenotypic variations Pneumonia Population Proteins SARS-CoV-2 Serology Severe acute respiratory syndrome coronavirus 2 Vaccination Variables Viral diseases |
title | Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A57%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deciphering%20the%20Longevity%20and%20Levels%20of%20SARS-CoV-2%20Antibodies%20in%20Children:%20A%20Year-Long%20Study%20Highlighting%20Clinical%20Phenotypes%20and%20Age-Related%20Variations&rft.jtitle=Pathogens%20(Basel)&rft.au=Pons-Tom%C3%A0s,%20Gemma&rft.date=2024-07-26&rft.volume=13&rft.issue=8&rft.spage=622&rft.pages=622-&rft.issn=2076-0817&rft.eissn=2076-0817&rft_id=info:doi/10.3390/pathogens13080622&rft_dat=%3Cproquest_doaj_%3E3097997862%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c376t-3c1df29233492a1026c7cd8e59edf8bfafb74870f970bf451fe4d2e45a24932f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3097997862&rft_id=info:pmid/39204223&rfr_iscdi=true |